期刊文献+

低通量血液透析对蛋白结合类毒素清除效果的研究 被引量:7

The clearance of protein-bound uremic toxins in low-flux hemodialysis
下载PDF
导出
摘要 目的探讨低通量血液透析(low-flux hemodialysis,LFHD)对维持性血液透析(maintenance hemodialysis,MHD)患者体内蛋白结合类毒素的清除效果。方法选择低通量血液透析治疗的MHD患者40例,采用高效液相色谱-串联质谱(high-performance liquid chromatography-tandem mass spectrometry,HPLC-MS/MS)法测定透析前、后血清中的马尿酸(hippuric acid,HA)、硫酸对甲酚(p-cresol sulphate,PCS)、硫酸吲哚酚(indoxyl sulphate,IS),3-羧基-4-甲基-5-丙基-2-呋喃丙酸(3-carboxy-4-methyl-5-propyl-2-furanpropionic acid,CMPF)的总体(Total,T)、游离(Free,F)浓度,计算其血清下降率和蛋白结合率。并测定透析废液中这4种蛋白结合类毒素的游离浓度,计算其溶质清除总量(total solute reduction,TSR)和透析溶质清除率(Kd),以观察低通量血液透析对蛋白结合类毒素的清除效果。结果透析后T-H A、T-PCS、T-IS及T-CMPF的血清下降率分别为(59.44±11.28)%、(32.36±9.28)%、(34.76±10.13)%和(5.60±15.98)%。透析废液中F-HA、F-PCS和F-IS的TSR分别为(112.88±31.72)mg、(31.55±9.85)mg和(35.40±10.38)mg;HA、PCS和IS的Kd分别为(41.25±5.09)ml/min、(8.09±3.58)ml/min、(9.89±2.76)ml/min。透析废液中CMPF极微量,基本测不出。结论低通量血液透析可以部分清除游离形式的蛋白结合类毒素;血清下降率并不足以评价低通量血液透析对蛋白结合类毒素的清除效果,蛋白结合类毒素在体内分布模型并非二室模型,可能为多室分布模型。 Objective To investigate the clearance of protein-bound uremic toxins in low-flux hemodialysis(LFHD) on maintenance hemodialysis(MHD) patients.Methods 40 patients with MHD from Air Force General Hospital were selected using high-performance liquid chromatography-tandem mass spectrometry(HPLC-MS/MS) method to determine the total and free serum concentration of hippuric acid(HA),p-cresol sulphte(PCS),indoxyl sulphate(IS),3-carboxy-4-methyl-5-propyl-2-furanpropionic aeid(CMPF) before and after dialysis.And reduction rates of these solutes were calculated.Using a continuous part of dialysate method to collect the waste dialysate during dialysis,the concentration of HA,PCS,IS and CMPF in the dialy sate was and then the total solute reduction(TSR) and dialytic solute clearances(Kd) of these substances was calculated,to observe the effect on protein-bound toxins with low-flux hemodialysis.Results The total serum concentration of HA,PCS and IS declined,compared with predialysis;their reduction rates were(59.44± 11.28)%,(32.36± 9.28)%and(34.76± 10.13)%,respectively,while the reduction rate of CMPF was(5.60± 15.98)%.Elimination of protein-bound toxins assessed by their mass in dialysate was(112.88± 31.72) mg for HA,(31.55± 9.85)mg for PCS and(35.40± 10.38)mg for IS,respectively.And the Kd of HA,PCS and IS were(41.25± 5.09)ml/min,(8.09± 3.58)ml/min,(9.89± 2.76)ml/min,while CMPF could not be measured in dialysate.Conclusion Low-flux hemodialysis can partially clear protein-bound toxins,which were mainly the free part of these toxins.Reduction rate are not valid tools to estimate total solute removal of protein-bound uremic retention solutes.Protein-bound toxins in vivo distribution may not be the two compartment models,but the multi-compartmental distribution model.
出处 《空军医学杂志》 2016年第2期106-109,共4页 Medical Journal of Air Force
关键词 低通量血液透析 蛋白结合类毒素 透析溶质清除量 透析溶质清除率 Hemodialysis Protein-bound toxins Dialysate solute mass Dialytic solute clearances
  • 相关文献

参考文献14

  • 1Zhang L,Wang F,Wang L,et al.Prevalence of chronic kidne3disease in China:a cross-sectional survey[J].Lancet,2012,379(9818):815-822.
  • 2Go AS,Chertow GM,Fan D,et al.Chronic kidney disease and therisks of death,cardiovascular events,and hospitalization[J].N Engl J Med,2004,351(13):1296-1305.
  • 3Itoh Y,Ezawa A,Kikuchi K,et al.Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production[J].Anal Bioanal Chem,2012,403(7):1841-1850.
  • 4邓岱,李新伦,李红霞,高卓,窦桂芳,伦立德.不同血液净化方法清除维持性血液透析患者血清蛋白结合类尿毒症毒素的效果比较[J].中国血液净化,2014,13(9):639-642. 被引量:36
  • 5任真真,伦立德.蛋白结合类尿毒症毒素蛋白结合率方法测定[J].空军医学杂志,2015,31(5):284-287. 被引量:3
  • 6Meijers B,Toussaint ND,Meyer T,et al.Reduction in ProteinBound Solutes Unacceptable as Marker of Dialysis Efficacy during Alternate-Night Nocturnal Hemodialysis[J].Am J Nephrol,2011,34(3):226-232.
  • 7Lin CJ,Liu HL,Pan CF,et al.Lndoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease[J].Arch Med Res,2012,43(6):451-456.
  • 8Palm F,Nangaku M,Fasching A,et al.Uremia induces abnormal oxygen consumption in tubules and aggravates chronic hypoxia of the kidney via oxidative stress[J].Am J Physiol Renal Physiol,2010,299(2):380-386.
  • 9Liabeuf S,Barreto DV,Barreto FC,et al.Free p-cresyl sulphate is a predictor of mortality in patients at different stages of chronic kidney disease[J].Nephrol Dial Transplant,2010,25(4):1 183-1 191.
  • 10Eknoyan G,Beck GJ,Cheung AK,et al.Effect of dialysis dose and membrane flux in maintenance hemodialysis[J].N Engl J Med,2002,347(25):2 010-2 019.

二级参考文献58

  • 1YueDongYANG,JiuGaoYU,YongGuoZHOU,PeiGuoLI.Preparation and Blood Compatibility of Oxidized-chitosan Films[J].Chinese Chemical Letters,2005,16(7):991-994. 被引量:2
  • 2梁志红,周长忍,林潮平,洪爱华,李国强.胶原、壳聚糖及其共混膜对红细胞的影响[J].高分子材料科学与工程,2006,22(6):161-164. 被引量:2
  • 3Xu Z K, Nie F Q, Qu C, et al. Tethering poly(ethylene glycol)s to improve the surface biocompat- ibility of poly (acrylonitrile- co- maleic acid) asymmetric membranes [J]. Biomaterials, 2005, 26: 589-598.
  • 4Deppisch R, Storr M, Buck R, et al. Blood material interactions at the surface of membranes in medical applications[J]. Sep Put Tech, 1998, 14:241 - 254.
  • 5Tsuruta T, Hayashi T, Kataoka K, et al. Biomedical applications of polymeric materials[M]. CRC Press, Boca Raton, FL,1993. 117- 142.
  • 6Kung F C, Yang M C. Effectof conjugated linoleic acid immobilization on the hemocompa- tibility of cellulose acetate membrane[J ]. Colloids and Surfaces B. Biointerfaces, 2006, 47: 36-42.
  • 7Akon H, Kazunobu S, Masaharu H, et al. Chemically modified polysulfone hollow fibers with vinylpyrrolidone having improved blood compatibility [ J ]. Biomaterials, 2002, 23:2659 - 2666.
  • 8王庆瑞,吴耀国,陈雪英,等.共混聚醚砜中空纤维透析膜的制造方法[P].中国专利:CN1375351A.2001-1228.
  • 9王庆瑞,陈雪英,段友容,等共混聚醚砜中空纤维透析膜、制造方法及其用途[P].中国专利:CN1631501A.2004-11-11.
  • 10陈雪英,王庆瑞,何春菊,等,人工肾血液透析器新材料及制造方法[P].中国专利:CN1317345A.2001-05-17.

共引文献48

同被引文献93

引证文献7

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部